MGteam

The CAR T-cell therapy called Descartes-08 is currently being studied in clinical trials. It's in Phase 3 trials (called the Aurora Trial) which is typically the final stage before potential FDA approval. This means it's not yet widely available outside of research settings.

The therapy is unique because it doesn't require Show Full Answer

The CAR T-cell therapy called Descartes-08 is currently being studied in clinical trials. It's in Phase 3 trials (called the Aurora Trial) which is typically the final stage before potential FDA approval. This means it's not yet widely available outside of research settings.

The therapy is unique because it doesn't require chemotherapy beforehand and is given as six weekly outpatient infusions. Early results have been promising, with over 80% of participants showing meaningful improvement in their MG symptoms. If you're interested in learning more about accessing this treatment, the best approach would be to:
1. Discuss this option with your neurologist
2. Ask about clinical trial participation opportunities
3. Stay connected with MGteam for updates on treatment availability

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

80% See MG Symptom Relief in Early Cell Therapy Trial